Innovative Cellular Therapeutics Holdings Ltd: insider trades.
Innovative Cellular Therapeutics Holdings Ltd reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($274), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Innovative Cellular Therapeutics Holdings Ltd
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | TenPercentOwner | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-27 | Lyell Immunopharma, Inc. | J | 38,500 | $0 | 2,818,980 | Form 4 |
| 2026-07-27 | Lyell Immunopharma, Inc. | J | 44,000 | $0 | 2,774,980 | Form 4 |
| 2026-07-17 | Lyell Immunopharma, Inc. | S | 10 | $13.7 | 2,857,480 | Form 4 |
| 2026-07-16 | Lyell Immunopharma, Inc. | S | 10 | $13.73 | 2,857,490 | Form 4 |
| 2026-06-29 | Lyell Immunopharma, Inc. | J | 76,000 | $0 | 2,857,500 | Form 4 |
Questions
What stock did Innovative Cellular Therapeutics Holdings Ltd buy or sell?
Innovative Cellular Therapeutics Holdings Ltd reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($274), across 1 company.
Is Innovative Cellular Therapeutics Holdings Ltd the same person as other filers with this name?
This page covers SEC CIK 2095697 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Plain-text version for agents and LLMs: /insiders/innovative-cellular-therapeutics-holdings-ltd-2095697.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.